21 January 2025
Full Year Trading Update and Notice of Results Marshalls, a leading manufacturer of sustainable solutions for the built environment, provides the following trading update…
20 January 2025
20 January 2025 Datroway (datopotamab deruxtecan) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer First approval in the US…
M. P. EVANS GROUP PLC (“THE GROUP”)2024 crop and production M.P. Evans Group PLC, a producer of sustainable Indonesian palm oil, is pleased to…
European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer · Expanded approval includes MMRp/MSS tumours, which represent…
17 January 2025
Two of London’s FTSE 100 heavyweight miners are reported to be in early stage talks about a merger that would create a commodities giant…
17 January 2025 Calquence plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma Based on ECHO Phase III trial results which…
16 January 2025
YOUNG & CO.’S BREWERY, P.L.C. (“Young’s”) Q3 FY25 TRADING UPDATE EXCELLENT CHRISTMAS TRADING Young’s, the premium operator of pubs and bedrooms in London and…
16 January 2025 Concurrent Technologies Plc (the “Company” or the “Group”) Trading Update Record year with revenue for FY24 expected to be c.25% ahead…